SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ROSENWALD LINDSAY A MD

(Last)

(First)

(Middle)

C/O CORONADO BIOSCIENCES, INC.

15 NEW ENGLAND EXECUTIVE PARK

(Street)

BURLINGTON

01803

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/13/2011

3. Issuer Name and Ticker or Trading Symbol
CORONADO BIOSCIENCES INC [ NONE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $.001 per share	2,047,632	D
Common Stock, par value $.001 per share	40,640	I	By Capretti Grandi, LLC
Common Stock, par value $.001 per share	42,676	I	By LAR Family Trusts
Common Stock, par value $.001 per share	71,303	I	By Paramount Biosciences
Common Stock, par value $.001 per share	100,000	I	By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01
Common Stock, par value $.001 per share	80,000	I	By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01
Common Stock, par value $.001 per share	720,000	I	By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00
Common Stock, par value $.001 per share	100,000	I	By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Common Stock	⁽¹⁾	10/05/2020	Common Stock	25,000	$1.37	D
Warrant to purchase Common Stock	04/26/2010	01/22/2014	Common Stock	17,878	$9.23	I	By Paramount Biosciences, LLC
Warrant to purchase Common Stock	04/26/2010	05/28/2014	Common Stock	3,337	$9.23	I	By Pramount Biosciences, LLC
Warrant to purchase Common Stock	04/26/2010	06/25/2014	Common Stock	5,960	$9.23	I	By Paramount Biosciences, LLC
Series A Convertible Preferred Stock	04/26/2010	⁽²⁾	Common Stock	98,164	$5.59	D
Series A Convertible Preferred Stock	04/26/2010	⁽²⁾	Common Stock	81,280	$5.59	I	By Capretti Grandi, LLC
Series A Convertible Preferred Stock	04/26/2010	⁽²⁾	Common Stock	142,607	$5.59	I	By Paramount Biosciences, LLC
Series A Convertible Preferred Stock	04/26/2010	⁽²⁾	Common Stock	85,353	$5.59	I	By LAR Family Trusts
Series B Convertible Preferred Stock	01/07/2011	⁽²⁾	Common Stock	82,536	$5.59	D
Series B Convertible Preferred Stock	01/07/2011	⁽²⁾	Common Stock	49,063	$5.59	I	By Capretti Grandi, LLC
Series B Convertible Preferred Stock	01/07/2011	⁽²⁾	Common Stock	528,951	$5.59	I	By Paramount Biosciences, LLC
Series B Convertible Preferred Stock	01/07/2011	⁽²⁾	Common Stock	325,793	$5.59	I	By LAR Family Trusts
Series C Convertible Preferred Stock	05/31/2011	⁽²⁾	Common Stock	214,669	$5.59	D

Explanation of Responses:

1. One-third of the shares will vest on each of October 5, 2011, 2012 and 2013.

2. Each share of Series A, B and C Convertible Preferred Stock shall be automatically converted into shares of Common Stock based on the then-effective conversion price immediately prior to the declaration or ordering of effectiveness of a resale registration filed by the issuer registering for resale by the holders thereof all of the Common Stock issuable upon conversion of the shares of Series A, B and C Convertible Preferred Stock.

	By: /s/ Lindsay A. Rosenwald	09/13/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.